Shenzhen Kangtai Biological Products Co Ltd banner

Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 14.2 CNY 1.36%
Market Cap: ¥15.9B

Wall Street
Price Targets

Price Targets Summary
Shenzhen Kangtai Biological Products Co Ltd

Wall Street analysts forecast Shenzhen Kangtai Biological Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 19.91 CNY with a low forecast of 17.17 CNY and a high forecast of 25.62 CNY.

Lowest
Price Target
17.17 CNY
21% Upside
Average
Price Target
19.91 CNY
40% Upside
Highest
Price Target
25.62 CNY
80% Upside
Shenzhen Kangtai Biological Products Co Ltd Competitors:
Price Targets
KNSA
Kiniksa Pharmaceuticals Ltd
21% Upside
CFFN
Capitol Federal Financial Inc
4% Upside
HCAT
Health Catalyst Inc
79% Upside

Revenue
Forecast

24% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
24% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 24%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

15% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss
15% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 46%.

Net Income
Forecast

21% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
21% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 40%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Kangtai Biological Products Co Ltd's stock price target?
Price Target
19.91 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 19.91 CNY with a low forecast of 17.17 CNY and a high forecast of 25.62 CNY.

What is Shenzhen Kangtai Biological Products Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 24%. The projected CAGR for the next 3 years is 14%.

What is Shenzhen Kangtai Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
46%

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 46%.

What is Shenzhen Kangtai Biological Products Co Ltd's Net Income forecast?
Projected CAGR
40%

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett